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ABSTRACT
BindingDB, www.bindingdb.org, is a publicly ac-
cessible database of experimental protein-small
molecule interaction data. Its collection of over a mil-
lion data entries derives primarily from scientific ar-
ticles and, increasingly, US patents. BindingDB pro-
vides many ways to browse and search for data of
interest, including an advanced search tool, which
can cross searches of multiple query types, including
text, chemical structure, protein sequence and nu-
merical affinities. The PDB and PubMed provide links
to data in BindingDB, and vice versa; and BindingDB
provides links to pathway information, the ZINC cat-
alog of available compounds, and other resources.
The BindingDB website offers specialized tools that
take advantage of its large data collection, including
ones to generate hypotheses for the protein targets
bound by a bioactive compound, and for the com-
pounds bound by a new protein of known sequence;
and virtual compound screening by maximal chemi-
cal similarity, binary kernel discrimination, and sup-
port vector machine methods. Specialized data sets
are also available, such as binding data for hundreds
of congeneric series of ligands, drawn from Bind-
ingDB and organized for use in validating drug de-
sign methods. BindingDB offers several forms of pro-
grammatic access, and comes with extensive back-
ground material and documentation. Here, we pro-
vide the first update of BindingDB since 2007, fo-
cusing on new and unique features and highlighting
directions of importance to the field as a whole.
INTRODUCTION
Launched on the web in 2000, BindingDB (www.bindingdb.
org) is the first publicly accessible database of measured
protein–ligand affinity data (1,2). It is designed to support
access to focused data sets, such as the affinity data associ-
ated with a particular drug target, as well as expansive anal-
yses taking advantage of the comprehensiveness of a large
and growing data set. For example, a medicinal chemist
might be satisfied with a compact set of affinity data for
a specific protein, in order to help with the design of new
or improved drugs targeting this protein; a computational
chemist might be interested inmachine-readable compound
and affinity data across a set of related targets, to test and
parameterize algorithms for computer-aided drug design;
and a pharmacologist might be interested in affinity data
across as many human proteins as possible, to help screen a
drug candidate for side effects or develop hypotheses for the
mechanism of action of a new bioactive compound. When
last described in the NARDatabase Issue in 2007 (2), Bind-
ingDB provided about 20 000 measured binding affinities.
Today, BindingDB supports these and other applications
with over a million binding data, for nearly 500 000 small
molecules and thousands of proteins, coupled with a range
of new tools for finding, viewing, downloading and integrat-
ing the information in this vast data set.
The BindingDB website is heavily and consistently used,
at about 9000 user sessions permonth, with an average of six
pages viewed per session. This represents a strong increase
from 2007, when there were about 2500 sessions per month,
with an average of four pages per session. Usage is world-
wide, as about one quarter of hits come from the United
States, one-eighth each come fromChina and India, and the
remaining half come from European Union member states,
Brazil, Japan, South Korea, Canada, Taiwan, Russia and
other countries. In addition to these web access statistics,
the fact that BindingDB data are downloaded thousands of
times a year points to substantial off line usage, not mea-
surable by web hits.
Here, we provide an update of BindingDB in 2015, fo-
cusing on its unique data sets and features, and its dramati-
cally expanded data holdings and functionalities. The pa-
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per is organized as follows: Section 3 describes the data,
how they are collected, and how they are linked with related
data in other bioinformatics resources; Section 4 discusses
connections between BindingDB and other databases; Sec-
tion 5 discusses the range of methods currently available
to browse, query and access the data; Section 6 presents
tools and data sets specialized for specific user communities;
Section 7 summarizes programmatic methods of accessing
BindingDB, such as its RESTful API; Section 8 describes
didactic materials, introductory tutorials and documenta-
tion to help users understand the data and use the features
of BindingDB; and Section 9 touches on key directions for
future work to secure and enhance access to protein–ligand
affinity data.
DATA COLLECTION
Continuous data collection efforts since BindingDB was
launched in 2000 have led to steady growth of the database.
BindingDB’s data holdings currently stand at about 1.1 mil-
lion measured protein-small molecule affinities, involving
about 490 000 small molecules and several thousand pro-
teins; further details regarding the composition and origins
of this data set may be found elsewhere (3). With a few ex-
ceptions, each BindingDB data entry is derived from one
publication (e.g. a scientific article or a patent) and contains
at least one protein target, at least one compound, at least
one associated compound–protein affinity, and information
on the source publication. Entries collected directly from
the literature by BindingDB staff also include extended in-
formation on experimental conditions like temperature, pH
and buffer composition. BindingDB also contains a mod-
est collection of measured protein–protein, protein–peptide
and host–guest affinities. The remainder of this section de-
scribes the sources of the data collection.
BindingDB staff collect many protein–ligand interaction
data not available through other public databases. One
aspect of this ongoing curation effort is the capture of
roughly 35 000 measurements per year from recent US
patents (www.bindingdb.org/bind/ByPatent.jsp). Most of
these protein–ligand affinity data are absent from the sci-
entific literature, and the BindingDB patent data set, un-
like SureChEMBL (www.surechembl.org), extracts quanti-
tative activity data for the patented compounds. In addi-
tion, BindingDB curators collect data on an ongoing basis
from about a dozen scientific journals not covered by other
database efforts. Primarily focused on the areas of chemical
biology and biochemistry, these journals often publish early
studies of proteins that later emerge as promising drug tar-
gets. They include ACS Chemical Biology, ChemBioChem,
Chemical Biology and Drug Design, Chemistry and Bi-
ology, and Nature Chemical Biology, ACS BioChemistry,
Bioorganic Chemistry and the Journal of Biological Chem-
istry. It is worth noting that BindingDB collects not only
the quantitative affinity data from the source materials, but
also key experimental conditions, notably the temperature,
buffer composition and pH.
BindingDB also harvests selected data from the Pub-
Chem (4,5), ChEMBL (6), PDSP Ki (7) and CSAR (8)
(www.csardock.org) databases, so that users can access an
integrated collection of protein–ligand affinity data through
BindingDB’s unified interface (see below). It is worth not-
ing, however, the data available from other databases typi-
cally are somewhat less detailed; in particular, they rarely in-
clude experimental details, like pH and temperature. Bind-
ingDB staff use a combination of automated and man-
ual procedures to import only measurements with a well-
defined protein target and a quantitative measure of affinity
or relative affinity (usually an IC50, Ki or Kd value), and to
flesh out entries as needed to conform to BindingDB’s rela-
tively stringent specifications. For example, phenotypic as-
say data in ChEMBL are not imported to BindingDB, since
they do not correspond unequivocally to binding affinities
for specific proteins. Similarly, only confirmatory assay re-
sults are collected from PubChem, as these are actual affin-
ity data derived from proper compound titrations. In con-
trast, compound screening data derived from large-scale ex-
periments with compounds at only a single concentration
are not imported from PubChem, because they do not pro-
vide quantitative affinities and are more liable to experi-
mental error than the confirmatory assay data. Importation
of the data from PDSP Ki involved substantial automated
and manual curation, such as supplementation of each en-
try with a protein sequence and experimental details from
associated publications.
BindingDB invites direct deposition of binding data by
experimentalists. The most straightforward approach uses
a simple, preformatted Excel file, which may be down-
loaded from the BindingDB website (www.bindingdb.org/
bind/contributedata.jsp). The user fills out the spreadsheet
and uploads it via the BindingDB website, and it is auto-
matically parsed for review and entry by BindingDB cu-
rators. Alternatively, data may be deposited via the same
web forms used by BindingDB curators (www.bindingdb.
org/deposition/index.jsp). Either way, direct deposition is
attractive because it eliminates transcription steps where er-
rors may creep in, and, if widely adopted, it would crowd-
source the time consuming process of data collection. Thus,
although only a negligible fraction of existing BindingDB
data have come by this route, routine deposition by experi-
mentalists remains a goal.
Several measures enhance the reliability of the data pro-
vided by BindingDB. First, data curated from original
sources by BindingDB staff are checked, and corrected if
needed, by a second staff member. Data imported from
other databases, such as PubChem and ChEMBL, are au-
tomatically checked for completeness and certain easily de-
tected errors, and any data flagged by these procedures are
reviewed manually and corrected if needed. For example,
data imported from other databases occasionally list im-
plausibly small pKi values, such as 1 × 10−8, usually be-
cause a curator mistakenly entered a Ki value as a pKi. Fi-
nally, automated scripts are used to identify the correspond-
ing author of each source article, where possible, and then
email the author a link to his or her data on the BindingDB
website, with an invitation to check the data and report any
errors. In addition to transcription errors, authors some-
times also report errors in the actual published article. In or-
der to avoid confusion in cases where BindingDB presents
corrected data, the BindingDB display marks the data as
having been corrected.
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Although BindingDB focuses primarily on experimental
data, it includes some––clearly marked––results from com-
putational modeling. In particular, SDfiles may be down-
loaded not only with 2D compound structures, but also
with 3D structures computed with the program Vconf
(www.verachem.com/products/vconf), which are suitable
starting points for further conformational analysis or dock-
ing calculations. Additionally, computed protein–ligand
poses, generated by automated docking with the program
Surflex (9), are provided for protein–ligand complexes for
which the crystal structure of a congeneric ligand (i.e. one
with a large shared substructure) is available to guide the
docking process. The full set of dockings are provided on
a single page (www.bindingdb.org/bind/surflex entry.jsp),
and are also presented in search results when available.
INTEGRATION WITH OTHER DATABASES
BindingDB is connected with a number of other databases
via either unidirectional (from BindingDB) or bidirectional
(to and from BindingDB) hyperlinks. The bidirectional
links between BindingDB and the RCSB (10) Protein Data
Bank (PDB) (11,12) are probably the most heavily used:
the home pages for many crystal structures in the PDB are
hyperlinked to the corresponding protein–small molecule
affinity data in BindingDB, and, conversely, many protein–
ligand affinity data in BindingDB are linked to co-crystal
structures in the PDB. It is worth noting, however, that only
a fraction of BindingDB’s affinity data are associated with
crystal structures. This is because, while medicinal chem-
istry publications frequently list on the order of 20 protein–
ligand affinities, only a few corresponding cocrystal struc-
tures appear in the PDB. This point clarifies a key difference
betweenBindingDBand theBindingMOAD (13) and PDB-
BIND (14,15) databases: the latter provide affinities only for
protein–ligand interactions associated with cocrystal struc-
tures, and hence contain well below 50 000 protein–ligand
affinities. BindingDB provides manymore affinities because
it is not limited to cases where a crystal structure is available.
BindingDB also provides direct links from data sets to
published articles andUSPatents online, as well as to article
entries in PubMed (www.ncbi.nlm.nih.gov/pubmed). Con-
versely, PubMed users may navigate directly from an arti-
cle listing to the corresponding data in BindingDB, via the
LinkOut/More Resources option below the PubMed ab-
stract. Many other precomputed links allow users to nav-
igate from BindingDB data to related information in other
databases. These include:
 Matching proteins in UniProt (16,17), BindingMOAD
and DrugBank (18)
 Matching compounds in ChEMBL, PubChem and
UniChem (19), as well as in the ZINC (20) database of
commercially available compounds
 Antibodies against protein targets, in AntibodyPedia
(www.antibodypedia.com)
 Links from the MarinLit (pubs.rsc.org/marinlit)
database of marine natural products to data for match-
ing compounds in BindingDB
 Links from BindingDB protein targets to biomolecular
pathway pages in Reactome (21–23)
BindingDB also participates in the Protein Standard In-
terface Common Query Interface (PSICQUIC; www.ebi.
ac.uk/Tools/webservices/psicquic/view/main.xhtml) (24), a
web service which provides standardized access to multiple
molecular interaction databases.
DISCOVERING AND VIEWING DATA IN BindingDB
BindingDB aims not only to collect data, but also tomake it
available in a user-friendly and flexible manner. The growth
of BindingDB’s data collection, the potential for new uses
of the data, and the emergence of new software technolo-
gies, have allowed the creation and deployment of inno-
vative tools for query, browsing, download, analysis, visu-
alization and integration. The present section highlights a
set of these tools that are particularly useful or distinctive.
First, however, we describe the primary report table, a cen-
tral data reporting format which is used by multiple brows-
ing and query tools.
Figure 1 displays the table header and a sample row
of such a table, for the androgen receptor binding to the
steroidal compound DHT. Moving from left to right, the
first column identifies the protein target and the institution
(e.g. a university or company) where the measurement was
made. The second column identifies the ligand and option-
ally shows the corresponding SMILES (25) or InChI (26)
strings. The next three columns respectively, provide links to
additional information about the target, the ligand, and the
target–ligand combination. For example, there are links to
more information about the androgen receptor in the PDB,
in several pathway databases, such as Reactome, in Drug-
Bank, and in AntibodyPedia; the ligand occurs in multiple
compound databases, including in ZINC with an availabil-
ity code of ‘1’, meaning that it is purchasable; and more
information about this ligand–target pair may be found in
the PDB and the source article. The Ligand Links column
also provides quick access to BindingDB data for chemi-
cally similar compounds via the ‘Similars’ link.
The gray tiles to the right then provide the quantitative
binding data, along with the pH and temperature at which
the measurement was made, if available. The Citation and
Details link goes to a page with additional information on
themeasurement, while the color icon links to an interactive
3D view of an available crystal or modeled structure (see be-
low). In some cases, multiplemeasurements are available for
a given protein and ligand; the ‘More data for this Ligand-
Target Pair’ is a link to such data in BindingDB, if it ex-
ists. The ‘Make Data Set’ button above each table of results
can be used to collect and download the displayed data in
machine-readable formats, either SDfile or a tab-separated
value (TSV) file with SMILES strings.
BindingDB provides a wide range of tools to query and
browse data. Most of these are available through the menu
of options at the lefthand side of the page, where they
are categorized as target-oriented, compound-oriented, ci-
tation oriented, etc. Due to space limitations, the following
subsections highlight only a few of the commonly used and
more specialized tools, and users are encouraged to visit the
website to explore the additional capabilities provided there.
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Figure 1. Sample data row in a standard BindingDB report. See text for details.
Query and browsing tools
Protein targets. The Simple Searchwindownear the top of
the home page provides an easy way to carry out a broad,
text-based search. The report page groups the resulting hits
according to whether the text matches occurred in the name
of a protein target, a compound, the title of an article or
the text of an assay description, and each hit can then be
followed to the associated data in BindingDB.
Another easy way in to the data set, for users who are in-
terested in a particular protein target, is to browse by target
name (www.bindingdb.org/bind/ByTargetNames.jsp), and
then follow the links provided to all information on a given
target, data subsetted by measurement type, such as Ki
or IC50, listings of the articles from which the data were
drawn, or direct download of all the data for a target of in-
terest in the form of a machine-readable SDfile or a TSV file
with SMILES strings.
The target-oriented tools also allow, among other things,
searching for data on a given target or targets with a user-
specified range of Ki or IC50 values; searching for rate con-
stant and calorimetric data; searching for data measured
within a given pH range; and searching for enzymatic data
with a desired substrate, a desired compound or a com-
pound within a desired molecular weight range. A spe-
cialized Pathways path merges information from Reactome
pathways with BindingDB data to help users find data for
proteins within pathways of interest.
Compound search. BindingDB provides two tools for
users interested in quick access to information on com-
pounds of relatively high general interest. One is a
page of FDA-approved products (www.bindingdb.org/
bind/ByFDAdrugs.jsp), which identifies the active ingre-
dients, the proteins against which they have been tested,
links to the corresponding binding data, and prepared
downloads with these data in machine-readable SDfile and
TSV formats. The second is a tabbed page of ‘Impor-
tant Compounds’ in simplified format (www.bindingdb.org/
ByLigandName), with separate tabs providing information,
drawn from BindingDB, DrugBank, ZINC, PubChem and
other sources, for existing drugs, experimental drugs, other
bioactive compounds of interest and peptides.
A tool to search for compounds according to chemical
structure, entered with a drawing or a SMILES or InChI
string (www.bindingdb.org/bind/chemsearch/marvin/
index.jsp), allows users to select among exact match, chem-
ical similarity and chemical substructure, while applying
additional criteria for compound potency against any
target, and whether the compound exists as a ligand in the
PDB. Also, one may use check boxes to define a limited
set of target proteins of interest. Finally, the ‘Find my
Compound’s Targets’ page, detailed below, can be used to
query BindingDB with multiple compounds uploaded in
the form of an SDfile or a text file with one SMILES string
in each line; again, options are provided to search by exact
match, similarity and substructure, and with user-specified
potency criteria. BindingDB uses current ChemAxon
default settings to compute chemical fingerprints, and
chemical similarities are then computed with the Tanimoto
metric.
Obtaining data by article, patent, author, institution, etc.
BindingDB provides the capability, apparently unique
among public protein–ligand databases, of direct access to
all of the binding data from an article or patent of interest.
The article page (www.bindingdb.org/bind/ByJournal.jsp)
allows users to select a curated article by journal name, vol-
ume and page number, and display it as a BindingDB ta-
ble or download it as a machine-readable file in SDfile or
TSV format; see, e.g. www.bindingdb.org/bind/ByJournal.
jsp?journal = J%20Med%20Chem. Similar browsers are
available to retrieve data from selected US Patents
(www.bindingdb.org/bind/ByPatent.jsp), PubChem BioAs-
says (www.bindingdb.org/bind/ByPCBioAssay.jsp) and ar-
ticles listed by PubMed IDs (www.bindingdb.org/bind/
ByPubMed.jsp). These tools provide a straightforward way
for users to collect the data from sources of interest, in
machine-readable formats suitable for importation to a
local database or for setting up calculations like QSAR
or simulations. For other useful perspectives of the Bind-
ingDB data collection, one may browse or search for
data from a specific author (http://www.bindingdb.org/
bind/ByAuthor.jsp) or from a specific company, university
or institute (www.bindingdb.org/bind/ByInstitution.jsp). It
is worth noting that a given institution may appear with
multiple names, chiefly because of variations in author us-
age.
BindingDB embeds journal reference data in its web
pages, in the form of ContextObjects in Spans (COinS;
ocoins.info). This allows users with suitable browser add-
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ons, such as the free Zotero (www.zotero.org) reference
manager, which integrates with Firefox, to collect all of the
journal references associated with the data displayed on a
BindingDB page with one or two mouse-clicks.
Biomolecular pathways and protein fold families. Reac-
tome is a manually curated and peer-reviewed pathway
database, which serves as a good starting point for re-
searchers seeking to learn more about signaling cascades,
metabolic pathways, etc. In order to enrich the BindingDB
user experience with this information, the Reactome Path-
way Browser (www.reactome.org/PathwayBrowser/) has
been repurposed as a point of entry for BindingDB users
seeking to obtain binding data for proteins associated with
a particular biological pathway of interest (www.bindingdb.
org/Pathways/pathways.jsp). A similar browsing tool pro-
vides users with a view into BindingDB based on protein
fold families (www.bindingdb.org/SCOP/scop.jsp), based
on the widely used SCOP classification (27).
Advanced search with multiple queries. In response to user
requests, a powerful advanced search capability has been
developed and deployed (www.bindingdb.org/as/search.
html). This allows users to specify any number of hetero-
geneous search criteria, and to limit the search to specific
sources within the BindingDB data set; i.e. data curated by
BindingDB; data from US Patents; and/or data harvested
from ChEMBL, PubChem, PDSP Ki or CSAR. Available
query criteria, whichmay be combinedwith a Boolean ‘and’
or ‘or’, include target name, sequence, molecular weight
and source organism; compound name, SMILES string,
molecular weight, similarity or substructure; binding po-
tency, such as Ki and IC50; and article or patent informa-
tion, such as publication year and author. For example, the
search in Figure 2 combines text in the target name, chem-
ical substructure and potency: tinyurl.com/puvu2ed. The
results are provided in the standard table format (above),
along with additional reports categorizing the data found
according to target, compound, article, patent, author, etc.
Downloading and reusing data
All BindingDB data are available for download and reuse,
chiefly in the form of SDfiles and TSV files with SMILES
strings. Documentation of both formats is provided at the
Info (https://www.bindingdb.org/bind/info.jsp) and Down-
load (https://www.bindingdb.org/bind/chemsearch/marvin/
SDFdownload.jsp?all download=yes) pages, and the SD-
files are available with 2D chemical structures or computed
3D structures. All data curated by BindingDB are provided
under a Creative Commons Attribution License which al-
lows reuse, redistribution and republication, so long as
BindingDB is cited. All data curated by ChEMBL are
provided, as required by ChEMBL, under a more restric-
tive Creative Commons Attribution-Share Alike License,
which, in addition to citation of ChEMBL, also requires
that any collection or product based on ChEMBL data
be redistributed under the same Share Alike license. Bind-
ingDB users are asked to complete a free registration, via
SSL encrypted pages, in order to download files. The reg-
istrations are important when we seek funding to continue
BindingDB, and they enable a brief survey of BindingDB
users once every few years to learn what is working, what
needs work, and what directions would be most useful.
As noted above, many of BindingDB’s query and brows-
ing tools allow the user to download the resulting data for
local use and redistribution. In addition, the Download
page provides downloadable files of all of the data in Bind-
ingDB, as an Oracle data dump or an SDfile or TSV file, as
well as of major subsets of BindingDB data. For example,
users who already have ChEMBL data may wish to obtain
only the data curated by BindingDB, only the patent data
curated by BindingDB, etc. Additional available downloads
include lists of target protein sequences, mappings of Bind-
ingDB entries to other databases, etc.
Customized data collection
Users with a long term interest in one or a few protein tar-
gets may use themyBDB feature of BindingDB to add them
to a personalized list of proteins, which may then be ac-
cessed and viewed in a compact format. In addition, users
may receive email notifications when new data for their tar-
gets appear. The myBDB feature is linked to one’s Bind-
ingDB user registration.
SPECIALIZED TOOLS AND DATA SETS
It was recognized early on that an expansive database of
protein–ligand interaction data would have emergent capa-
bilities, such as the ability to formulate hypotheses for the
protein targets of bioactive compounds, to raise flags re-
garding possible off-target effects of drugs and drug candi-
dates (28), and to generate suggestions for old compounds
to test against new protein targets. In addition, easy avail-
ability of a large set of quantitative binding data should pro-
vide a valuable basis for the evaluation and parameteriza-
tion of software for computer-aided ligand design. Bind-
ingDB supports such applications with specialized tools
and data sets, as described in the following subsections.
Find my compound’s target
The experimental observation that a compound is bioactive,
such as through phenotypic screening, immediately poses
the question of its mechanism of action. BindingDB’s large
data set can be used to generate hypotheses regarding the
target or targets of bioactive compounds, based on a sim-
ple transitivity principle: a compound A, which is chemi-
cally similar to another compound B, has a good chance of
binding the same proteins that B binds. Thus, the targets
of compound B may explain the mechanism of compound
A. Similarly, if A is a drug, it may generate off-target side
effects by binding some of the same targets as compound B.
BindingDB’s Find My Compound’s Target (FMCT)
tool (www.bindingdb.org/bind/chemsearch/marvin/
BatchStructures.jsp) is designed to support such anal-
yses. Here, one specifies a single compound of interest as
a chemical drawing, SMILES string or InChI string; or
multiple compounds of interest by uploading an SDfile or
a text file with one SMILES string per line. These are the
A compounds. One then adjusts the chemical similarity
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Figure 2. Example of advanced search, based on name of protein, numerical range of IC50 and chemical structure similarity. Results are shown at the
bottom of the figure.
criteria to be applied in finding the B compounds, and sets
an optional filter for the affinity with which the B com-
pounds must bind a protein target in order for the protein
to be reported as a possible target of the A compounds.
The results of the query are presented in a table (Figure 3),
where each row lists one suggested protein target, the max-
imum similarity of query compound A to any compound
B binding this target, links to the compound(s) B and their
associated affinity data, and downloadable files with the
compound(s) B and their affinities for the target. Figure 3
shows part of the table of results for a query with the cough
suppressant cloperastine, which has been analyzed with
the Similarity Ensemble Approach (SEA (29)). Clearly,
this compound has high potential to bind a variety of
Nucleic Acids Research, 2016, Vol. 44, Database issue D1051
Figure 3. Sample results table from the Find My Compound’s Target tool, with cloperastine as the query compound.
membrane-bound receptors and transporters in the central
nervous system, and the sigma receptor prediction (last
row) is consistent with recent experimental confirmation
(30). Further examples and analysis of BindingDB’s FMCT
tools are available in a separate publication (31).
Find compounds for my targets
Users looking for candidate compounds to bind a new pro-
tein target of interest may take advantage of the ‘Find Com-
pounds for My Targets’ (FCMT: www.bindingdb.org/as/
targetsearch.html) tool, which is based on a mirror image
of the reasoning used to find targets for compounds, above.
Thus, if a protein A is similar in amino acid sequence to a
protein B, it is likely to bind some of the same compounds as
protein B. Here, one pastes one or more protein sequences
into text windows, specifies a sequence identity cutoff, and
then searches for compounds which bind any protein in
BindingDB whose sequence identity with the query pro-
tein(s) satisfies the cutoff. The results may be sorted by affin-
ity, the number of similar targets found or other parame-
ters, and may be downloaded in the form of an Excel (xls)
file containing the SMILES strings and binding informa-
tion for the compound hits.
Virtual compound screening
BindingDBprovides web-based tools that allow users to up-
load a set of active compounds, or to pick a set of Bind-
ingDB compounds that bind a protein target of interest,
and then use these actives as a basis for computationally
screening a compound catalog for other compounds likely
to have the same activity. The available methods for this
ligand-based screening service areMaximum Similarity, Bi-
nary Kernel Discrimination (32) and a Support Vector Ma-
chine (33) approach.
Validation data sets for computer-aided drug design
The BindingDB data collection can be used to train
and evaluate software for computer-aided ligand design.
This application is specifically supported by a page with
700 focused, downloadable data sets drawn from the
larger BindingDB data collection (http://www.bindingdb.
org/validation sets/index.jsp). Each data set comprises 10–
50 congeneric compounds spanning a range of affinities for
a single protein target. For each data set, the PDB holds a
protein–ligand cocrystal structure of at least one of the com-
pounds in the series. This index structure provides a basis
for modeling the rest of the compounds in the series, and,
as noted above, docked structures are provided for many of
them, in order to provide users with an initial look at a plau-
sible range of ligand poses. The publications which yielded
the data in each data set are also provided at the validation
set web page, and it is worth emphasizing thatmost data sets
are derived fromonly 1–3 articles published by a single insti-
tution, so the affinities in each data set are usually traceable
to a single experimental assay procedure. This uniformity is
beneficial, as it avoids concerns about comparing affinities
measured by different assays at different institutions. Each
data set also has a place for users to leave public comments,
such as if a particular data set is found to be particularly
useful or problematic.
PROGRAMMATIC ACCESS
The BindingDB server provides two different types of
programmatic access. One is a RESTful API (https:
//www.bindingdb.org/bind/BindingDBRESTfulAPI.jsp),
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which provides two types of access to binding data,
returned in XML format. In one, the user provides the
UniProt ID of a protein of interest, and BindingDB returns
a list of BindingDB compounds (BindingDB Monomer
IDs and SMILES strings) and their affinities for the query
protein. In the other, the user provides a SMILES string
and a chemical similarity cutoff, and BindingDB returns a
list of similar compounds, along with their protein targets
and the corresponding binding affinities.
The BindingDB website also supports various queries
with structured URLs (https://www.bindingdb.org/bind/
SearchTemplates.jsp), which return a BindingDB web page
with the search results. For example, the following URL
returns the binding data associated with PDB entry 1OKZ:
www.bindingdb.org/jsp/dbsearch/PrimarySearch pdbids.
jsp?pdbids submit = Search&pdbids = 1OKZ; note
that the full list of PDB entries represented in Bind-
ingDB is also available: https://www.bindingdb.org/
bind/BindingDB PDB.txt. Similarly, one may re-
cover all of the data associated with a given article
(i.e. PubMed ID), and there is a corresponding list
of PubMed IDs for which BindingDB holds data:
www.bindingdb.org/bind/BindingDB PubMed.txt. Struc-
tured URLs area also available to query BindingDB by
protein target name, protein sequence (via BLAST (34)),
BindingDB compound monomerID and SMILES string.
Finally, BindingDB has been successfully linked to
KNIME (35), a graphical workbench for data analysis,
analytics, visualization and reporting (www.knime.org/).
KNIME allows data analyses to be set up by interactively
linking functional ‘nodes’ into custom pipelines which can
then be used and shared. Over 1000 nodes are currently
available, including many for chemical computing and
analysis, so connecting BindingDB with this analysis
environment holds great potential to facilitate the flexible
use and reuse of binding data in a variety of applications.
As detailed elsewhere (31), KNIME workflows have been
constructed that query BindingDB in two modes. One
mode is to access the RESTful API; the second is to access
with a local, downloaded table containing essentially
all BindingDB data. The latter approach is particularly
useful for large scale queries or work where confiden-
tiality is of high concern. Ten KNIME workflows and
their associated documentation, including a full KNIME
implementation of the Find My Compound’s Target tool
(Section 6.1), are available for free download and reuse
(https://www.bindingdb.org/bind/chemsearch/marvin/
SDFdownload.jsp?all download = yes).
DOCUMENTATION AND INSTRUCTIONAL RE-
SOURCES
TheBindingDBwebsite provides a range of documentation,
chiefly through the Info page, https://www.bindingdb.org/
bind/info.jsp, including:
 Didactic background regarding the science of protein–
ligand binding and how affinities are measured, suit-
able for suitable for students and interested scien-
tists from other fields: https://www.bindingdb.org/bind/
BindingDB-Intro2a.pdf
 A ‘how to’ page with explanations of common searches
and answers to frequently asked questions: www.
bindingdb.org/bind/FAQ2.jsp
 A glossary of BindingDB terminology: www.bindingdb.
org/bind/glossary.jsp
 Documentation of BindingDB’s structured URLs (Sec-
tion 7) and download file formats
 Link to the BindingDB on Wikipedia: en.wikipedia.org/
wiki/BindingDB
 Four video tutorials regarding commonly used Bind-
ingDB tools, accessible via links on the BindingDBmain
page.
DIRECTIONS
Continuing the flow of new data into BindingDB and other
protein–ligand interaction databases is both fundamental
and non-trivial. Great strides have been made through
the manual extraction of data from scientific articles and
patents, notably by ChEMBL and BindingDB. However,
ensuring the stability of these efforts may require a broader
recognition, by the scientific community and funding agen-
cies, that the collection of protein–ligand interaction data is
a priority on par with collection of other types of data, such
as protein structures and gene sequences, due to its critical
value in the translation of basic science to therapeutics. It is
also worth noting that the need for manual curation would
be greatly reduced if journals were to establish a regular flow
of the data being published in their articles into a common
data collection portal, from which the information could be
transferred into the relevant databases. Such data flowsmay
be facilitated by the growing use of electronic lab notebooks
and other research data systems. Ultimately, authors should
be able to move the data they are publishing into both jour-
nals and databases with a few keystrokes.
Today, the availability of large, publicly accessible
databases of protein–ligand interaction data, such as Bind-
ingDB, is actively transforming the landscape of molecu-
lar informatics (3), enabling new linkages among diverse
fields likemedicinal chemistry, drug discovery, systems biol-
ogy and genomics. Indeed, there are still exciting opportuni-
ties for new tools to take advantage of these data, through
seamless integration of data resources and computational
tools both on- and off-line. For example, the growing field
of systems pharmacology (36–38) would benefit from ad-
vanced tools to markup pathways with compounds known
to modulate the proteins involved, and to smoothly access
target–compound data in support of ligand-design and the
prediction of side effects. In addition, there is potential for
tighter integration with journals, by linking articles to as-
sociated binding and structural data in machine-readable
format, and by using these data to bring electronic arti-
cles to life with structural views, structure-activity spread-
sheets and charts, and facile integration with data for simi-
lar compounds and related proteins. The continued expan-
sion of the data collections, and of capabilities in comput-
ing, networking, visualization and informatics, point only
to growth in the power and utility of BindingDB and its re-
lated resources.
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